A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
|
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
  • [31] Transarterial Chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis -: Experiences
    Herber, S.
    Pitton, M.
    Moench, C.
    Schneider, J.
    Manzl, N.
    Kummer, I.
    Kanzler, S.
    Schuchmann, M.
    Junginger, T.
    Dueber, C.
    Otto, G.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (04): : 306 - 315
  • [32] Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis
    Georgiades, CS
    Hong, K
    D'Angelo, M
    Geschwind, JFH
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (12) : 1653 - 1659
  • [33] Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis
    Abdella H.
    Shaker M.K.
    Montasser I.F.
    Sobhi M.
    Aly H.
    Sayed A.
    Saleh S.
    El Dorry A.
    Indian Journal of Gastroenterology, 2018, 37 (2) : 127 - 132
  • [34] Transarterial ethanol ablation combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
    Yang, B.
    Liao, Z.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Yang, Biao
    You, Xin
    Yuan, Min Lan
    Qin, Tian Qiang
    Duan, Lin Jia
    He, Jiao
    Fei, Ze Jun
    Zhou, Xuan
    Zan, Rui Yu
    Liao, Zheng Yin
    HEPATITIS MONTHLY, 2016, 16 (08)
  • [36] Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification
    Zhi-Jie Niu
    Yi-Long Ma
    Ping Kang
    Sheng-Qiu Ou
    Zhi-Bin Meng
    Zhi-Kun Li
    Feng Qi
    Chang Zhao
    Medical Oncology, 2012, 29 : 2992 - 2997
  • [37] Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification
    Niu, Zhi-Jie
    Ma, Yi-Long
    Kang, Ping
    Ou, Sheng-Qiu
    Meng, Zhi-Bin
    Li, Zhi-Kun
    Qi, Feng
    Zhao, Chang
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2992 - 2997
  • [38] Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis
    Lei, Zilun
    Chai, Hao
    Liu, Xiaoya
    Jiang, Yingsong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (02): : 517 - 532
  • [39] Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
    Lee, Jung Min
    Jang, Byoung Kuk
    Lee, Yoo Jin
    Choi, Wang Yong
    Choi, Sei Myong
    Chung, Woo Jin
    Hwang, Jae Seok
    Kang, Koo Jeong
    Kim, Young Hwan
    Chauhan, Anil Kumar
    Park, Soo Young
    Tak, Won Young
    Kweon, Young Oh
    Kim, Byung Seok
    Lee, Chang Hyeong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (01) : 160 - 167
  • [40] Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
    Po-Hong Liu
    Yun-Hsuan Lee
    Cheng-Yuan Hsia
    Chia-Yang Hsu
    Yi-Hsiang Huang
    Yi-You Chiou
    Han-Chieh Lin
    Teh-Ia Huo
    Annals of Surgical Oncology, 2014, 21 : 1825 - 1833